Verrica Pharmaceuticals to Discuss Q2 Financials and Phase 2 Trial Results

Verrica Pharmaceuticals Inc

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has scheduled a conference call and live webcast for 8:30 a.m. ET on Wednesday, August 14, 2024. The company will discuss its financial results for the second quarter ended June 30, 2024, and present topline results from Part 2 of the Phase 2 trial of VP-315 for treating basal cell carcinoma.

To join the live call, dial 1-800-579-2543 for domestic participants or 1-785-424-1789 for international participants, using conference ID: VERRICA. Please dial in 10 minutes before the start to register.

A live audio webcast will be available on the investor relations section of Verrica’s website. The webcast replay will be archived on the website for 90 days following the event.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  Revolutionizing Retail: Cantaloupe’s Smart Stores Tackle Theft, Labor Shortages, and Expand Possibilities